Original Article

Predictive Value of Serum Calprotectin Level in Response to Treatment, a New Inflammatory Marker in Patients with Breast Cancer Requesting Neoadjuvant Treatment
  • Ece BAYDAR
  • Aliye ÇELİKKOL
  • Sibel ÖZKAN GÜRDAL
  • Selçuk ŞEBER
Namik Kemal Med J 2023; 11: 12-16 DOI: 10.4274/nkmj.galenos.2023.61587
Clinicopathological Factors Determining the Pathological Response to Neoadjuvant Therapy in HER2 Positive Breast Cancer
  • Abdullah Evren YETİŞİR
  • Semra PAYDAŞ
Namik Kemal Med J 2021; 9: 179-183 DOI: 10.4274/nkmj.galenos.2021.32932
Effects of COVID-19 Pandemic on Diagnosis-treatment Process in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
  • Eyyüp ÇAVDAR
  • Yakup İRİAĞAÇ
  • Kubilay KARABOYUN
  • Okan AVCI
  • Erdoğan Selçuk ŞEBER
Namik Kemal Med J 2021; 9: 255-260 DOI: 10.4274/nkmj.galenos.2021.69775